Exelixis Inc. (EXEL) Price Targets: What Do They Mean?

As of Wednesday close, Exelixis Inc.’s (NASDAQ:EXEL) stock was up $0.84, moving up 4.34 percent to $20.19. The average number of shares traded per day over the past five days has been 4,216,080 shares. 4 times new highs have been achieved over the past 5 days, with a $2.52 gain in that time frame. In the last twenty days, the average volume was 2,898,490, while in the previous 50 days, it was 2,892,812.

Since last month, EXEL stock rose 13.68%. Shares of the company fell to $17.36 on 06/14/22, the lowest level in the past month. A 52-week high of $23.52 was reached on 04/05/22 after having rallying from a 52-week low of $15.50. Since the beginning of this year, EXEL’s stock price has risen by 10.45% or $1.91, and marked a new high 22 times. However, the stock has declined by -14.16% since its 52-week high.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


Exelixis Inc. (EXEL) last reported insider trading activity 27 days ago on May 27. Haley Patrick J., the EVP, Commercial of the company, disposed of 18,812 shares for $18.21 on May 27. It resulted in a $342,567 divestment by the insider. WILLSEY LANCE sold 40,000 shares at an average price of $19.65 on May 12. The insider now owns 424,415 shares following the transaction. On Apr 04, Director WYSZOMIERSKI JACK L sold 6,696 shares at $23.00 apiece. The transaction was valued at $154,008.

Valuation Metrics

Right now, Exelixis Inc. (EXEL) has a P/E ratio of about 21.87. The stock’s beta is 0.73. Besides these, the trailing price-to-sales (P/S) ratio of 4.03, the price-to-book (PB) ratio of 2.81, and the price-to-cash flow ratio of 13.54 may also be considered.

Financial Health

In the three months ended March 30, Exelixis Inc.’s quick ratio stood at 6.30, while its current ratio was 6.40, showing that the company is able to pay off its debt. On the profitability front, the trailing twelve-month gross margin is 96.50% percent. In the year ended March 30, operating margins totaled 24.60%. Based on annual data, EXEL earned $1.38 billion in gross profit and brought in $1.43 billion in revenue.

A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was 10.10%. Return on equity (ROE) for the past 12 months was 13.80%.

According to the earnings report, the company had a lower net income in the recent quarter than it did in the previous quarter. EXEL’s revenue rose 24.09% to $451.14 million during the quarter, while net income inched up to $355.98 million. While analysts expected Exelixis Inc. to report $0.14 quarterly earnings, the actual figure was $0.21 per share. During the quarter, the company generated $87.73 million in EBITDA. The liabilities of Exelixis Inc. were 360.27 million at the end of its most recent quarter ended March 30, and its total debt was $56.41 million. The value of shareholders’ equity is $320.74 million.

Technical Picture

This quick technical analysis looks at Exelixis Inc.’s (EXEL) price momentum. With a historical volatility rate of 51.87%, the RSI 9-day stood at 67.43% on 22 June.

With respect to its five-day moving average, the current Exelixis Inc. price is up by +14.26% percent or $2.52. At present, EXEL shares trade +13.75% above its 20-day simple moving average and +15.90% percent above its 100-day simple moving average. However, the stock is currently trading approximately -12.29% below its SMA50 and +2.12% above its SMA200.

Stochastic coefficient K was 80.84% and Stochastic coefficient D was 62.88%, while ATR was 0.76. Given the Stochastic reading of 94.96% for the 14-day period, the RSI (14) reading has been calculated as 59.47%. As of today, the MACD Oscillator reading stands at 0.93, while the 14-day reading stands at 0.71.

Analyst Ratings

Piper Sandler launched its rating on Exelixis Inc. (NASDAQ: EXEL) to an Overweight in a note to investors on November 19, 2021. Exelixis Inc. (EXEL) has been rated Overweight by analysts. According to 1 brokerage firm, EXEL is a sell, and 2 firms recommend it is a Hold. There are 1 analyst who say the stock is underweight. A total of 1 analyst rate Exelixis Inc. stock as buy, with 9 recommending it as overweight.

With a median target price of $28.50, the current consensus forecast for the stock is $18.00 – $35.00. Based on these forecasts, analysts predict Exelixis Inc. (EXEL) will achieve an average price target of $27.08.


Please enter your comment!
Please enter your name here

Hot Topics

Related Articles




Download Free eBook For

The 5 Best Growth Stocks 2022

100% free. stop anytime no spam